• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗癌药物玫瑰树碱通过代谢生成13-羟基玫瑰树碱和玫瑰树碱N2-氧化物,由人细胞色素P450介导形成共价DNA加合物。

The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N2-oxide.

作者信息

Stiborová Marie, Sejbal Jan, Borek-Dohalská Lucie, Aimová Dagmar, Poljaková Jitka, Forsterová Kristina, Rupertová Martina, Wiesner Jirí, Hudecek Jirí, Wiessler Manfred, Frei Eva

机构信息

Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic.

出版信息

Cancer Res. 2004 Nov 15;64(22):8374-80. doi: 10.1158/0008-5472.CAN-04-2202.

DOI:10.1158/0008-5472.CAN-04-2202
PMID:15548707
Abstract

Ellipticine is an antineoplastic agent, the mode of action of which is considered to be based on DNA intercalation and inhibition of topoisomerase II. We found that ellipticine also forms the cytochrome P450 (CYP)-mediated covalent DNA adducts. We now identified the ellipticine metabolites formed by human CYPs and elucidated the metabolites responsible for DNA binding. The 7-hydroxyellipticine, 9-hydroxyellipticine, 12-hydroxyellipticine, 13-hydroxyellipticine, and ellipticine N(2)-oxide are generated by hepatic microsomes from eight human donors. The role of specific CYPs in the oxidation of ellipticine and the role of the ellipticine metabolites in the formation of DNA adducts were investigated by correlating the levels of metabolites formed in each microsomal sample with CYP activities and with the levels of the ellipticine-derived deoxyguanosine adducts in DNA. On the basis of this analysis, formation of 9-hydroxyellipticine and 7-hydroxyellipticine was attributable to CYP1A1/2, whereas production of 13-hydroxyellipticine and ellipticine N(2)-oxide, the metabolites responsible for formation of two major DNA adducts, was attributable to CYP3A4. Using recombinant human enzymes, oxidation of ellipticine to 9-hydroxyellipticine and 7-hydroxyellipticine by CYP1A1/2 and to 13-hydroxyellipticine and N(2)-oxide by CYP3A4 was corroborated. Homologue modeling and docking of ellipticine to the CYP3A4 active center was used to explain the predominance of ellipticine oxidation by CYP3A4 to 13-hydroxyellipticine and N(2)-oxide.

摘要

椭圆玫瑰树碱是一种抗肿瘤药物,其作用方式被认为基于DNA嵌入和拓扑异构酶II的抑制。我们发现椭圆玫瑰树碱还能形成细胞色素P450(CYP)介导的共价DNA加合物。我们现已鉴定出由人CYP形成的椭圆玫瑰树碱代谢产物,并阐明了负责DNA结合的代谢产物。7-羟基椭圆玫瑰树碱、9-羟基椭圆玫瑰树碱、12-羟基椭圆玫瑰树碱、13-羟基椭圆玫瑰树碱和椭圆玫瑰树碱N(2)-氧化物由来自八名人类供体的肝微粒体产生。通过将每个微粒体样品中形成的代谢产物水平与CYP活性以及DNA中椭圆玫瑰树碱衍生的脱氧鸟苷加合物水平相关联,研究了特定CYP在椭圆玫瑰树碱氧化中的作用以及椭圆玫瑰树碱代谢产物在DNA加合物形成中的作用。基于此分析,9-羟基椭圆玫瑰树碱和7-羟基椭圆玫瑰树碱的形成归因于CYP1A1/2,而13-羟基椭圆玫瑰树碱和椭圆玫瑰树碱N(2)-氧化物(负责形成两种主要DNA加合物的代谢产物)的产生归因于CYP3A4。使用重组人酶证实了CYP1A1/2将椭圆玫瑰树碱氧化为9-羟基椭圆玫瑰树碱和7-羟基椭圆玫瑰树碱,以及CYP3A4将其氧化为13-羟基椭圆玫瑰树碱和N(2)-氧化物。利用椭圆玫瑰树碱与CYP3A4活性中心的同源建模和对接来解释CYP3A4将椭圆玫瑰树碱氧化为13-羟基椭圆玫瑰树碱和N(2)-氧化物的优势。

相似文献

1
The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N2-oxide.抗癌药物玫瑰树碱通过代谢生成13-羟基玫瑰树碱和玫瑰树碱N2-氧化物,由人细胞色素P450介导形成共价DNA加合物。
Cancer Res. 2004 Nov 15;64(22):8374-80. doi: 10.1158/0008-5472.CAN-04-2202.
2
Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems.抗癌药物椭圆玫瑰树碱在肝微粒体中的氧化模式——人与大鼠系统之间的相似性
Gen Physiol Biophys. 2006 Sep;25(3):245-61.
3
Cytochromes P450 reconstituted with NADPH: P450 reductase mimic the activating and detoxicating metabolism of the anticancer drug ellipticine in microsomes.用NADPH:P450还原酶重构的细胞色素P450模拟微粒体中抗癌药物玫瑰树碱的活化和解毒代谢。
Neuro Endocrinol Lett. 2006 Dec;27 Suppl 2:18-22.
4
Ellipticine oxidation and DNA adduct formation in human hepatocytes is catalyzed by human cytochromes P450 and enhanced by cytochrome b5.依利替康的氧化和人肝细胞核中 DNA 加合物的形成是由人细胞色素 P450 催化的,并可被细胞色素 b5 增强。
Toxicology. 2012 Dec 16;302(2-3):233-41. doi: 10.1016/j.tox.2012.08.004. Epub 2012 Aug 16.
5
The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells.抗癌药物玫瑰树碱在人神经母细胞瘤细胞中产生细胞毒性及形成DNA加合物的机制
Biochem Pharmacol. 2009 May 1;77(9):1466-79. doi: 10.1016/j.bcp.2009.01.021. Epub 2009 Feb 13.
6
Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans.能将抗癌药物玫瑰树碱激活为可与DNA中的脱氧鸟苷共价结合的物质的大鼠微粒体,是模拟玫瑰树碱在人体内生物活化的合适模型。
Chem Res Toxicol. 2003 Jan;16(1):38-47. doi: 10.1021/tx0200818.
7
Cytochrome b(5) shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy.细胞色素 b(5)将抗癌药物椭圆屈麻津的细胞色素 P450 1A1 和 1A2 的氧化从解毒转化为激活,从而调节其药理作用。
Biochem Pharmacol. 2011 Sep 15;82(6):669-80. doi: 10.1016/j.bcp.2011.06.003. Epub 2011 Jun 13.
8
Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells.椭圆玫瑰树碱在人U87MG胶质母细胞瘤癌细胞中的细胞毒性及DNA加合物形成
Neuro Endocrinol Lett. 2009;30 Suppl 1:60-6.
9
Mammalian peroxidases activate anticancer drug ellipticine to intermediates forming deoxyguanosine adducts in DNA identical to those found in vivo and generated from 12-hydroxyellipticine and 13-hydroxyellipticine.哺乳动物过氧化物酶将抗癌药物玫瑰树碱激活为中间体,这些中间体在DNA中形成与体内发现的以及由12-羟基玫瑰树碱和13-羟基玫瑰树碱产生的脱氧鸟苷加合物相同的加合物。
Int J Cancer. 2007 Jan 15;120(2):243-51. doi: 10.1002/ijc.22247.
10
Antitumor drug ellipticine inhibits the activities of rat hepatic cytochromes P450.抗肿瘤药物玫瑰树碱抑制大鼠肝细胞色素P450的活性。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Dec;149(2):437-40.

引用本文的文献

1
Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review.人类细胞色素P450与癌症相关的代谢活性及基因多态性:综述
Cells. 2024 Nov 26;13(23):1958. doi: 10.3390/cells13231958.
2
Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes.药物在人药物代谢酶催化反应中形成潜在毒性代谢物。
Arch Toxicol. 2024 Jun;98(6):1581-1628. doi: 10.1007/s00204-024-03710-9. Epub 2024 Mar 23.
3
Study on the absolute configuration and biological activity of rotenoids from the leaves and twigs of Millettia pyrrhocarpa Mattapha, Forest & Hawkins, sp. Nov.
研究新型密花胡颓子叶和枝中的类柠檬素的绝对构型和生物活性
BMC Complement Med Ther. 2023 May 4;23(1):147. doi: 10.1186/s12906-023-03963-4.
4
Pharmacological blockage of the AHR-CYP1A1 axis: a call for in vivo evidence.阻断 AHR-CYP1A1 轴的药理学作用:呼吁体内证据。
J Mol Med (Berl). 2022 Feb;100(2):215-243. doi: 10.1007/s00109-021-02163-2. Epub 2021 Nov 20.
5
Extending the Applicability of and Chicken Chorioallantoic Membrane Assays to Study Cytostatic Activity in Neuroblastoma Cells.扩展鸡胚绒毛尿囊膜试验在神经母细胞瘤细胞中研究细胞抑制活性的适用性。
Front Oncol. 2021 Sep 1;11:707366. doi: 10.3389/fonc.2021.707366. eCollection 2021.
6
Bioactive Olivacine Derivatives-Potential Application in Cancer Therapy.生物活性橄榄酰胺衍生物——在癌症治疗中的潜在应用
Biology (Basel). 2021 Jun 21;10(6):564. doi: 10.3390/biology10060564.
7
Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.人类家族 1-4 细胞色素 P450 酶参与外源化学物和生理化学物质的代谢激活:更新。
Arch Toxicol. 2021 Feb;95(2):395-472. doi: 10.1007/s00204-020-02971-4. Epub 2021 Jan 18.
8
Identification of Enzymes Oxidizing the Tyrosine Kinase Inhibitor Cabozantinib: Cabozantinib Is Predominantly Oxidized by CYP3A4 and Its Oxidation Is Stimulated by cyt b Activity.氧化酪氨酸激酶抑制剂卡博替尼的酶的鉴定:卡博替尼主要由CYP3A4氧化,其氧化受细胞色素b活性的刺激。
Biomedicines. 2020 Nov 28;8(12):547. doi: 10.3390/biomedicines8120547.
9
Application of hepatic cytochrome b/P450 reductase null (HBRN) mice to study the role of cytochrome b in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine.应用肝细胞色素 b/P450 还原酶缺失(HBRN)小鼠研究细胞色素 b 在细胞色素 P450 介导的抗癌药物椭圆醇生物活化中的作用。
Toxicol Appl Pharmacol. 2019 Mar 1;366:64-74. doi: 10.1016/j.taap.2019.01.020. Epub 2019 Jan 25.
10
Synthesis and Activity against of Olivacine and Oxygenated Derivatives.橄榄苦苷及其含氧衍生物的合成与活性研究。
Molecules. 2018 Jun 9;23(6):1402. doi: 10.3390/molecules23061402.